1 |
Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;1:CD004816.
|
2 |
Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2014;129(25 Suppl 2):S1-45.
DOI
ScienceOn
|
3 |
National Institute for Health and Care Excellence. Lipid modification (update): draft full guideline. England: National Institute for Health and Care Excellence, 2014. Available from: http://www.nice.org.uk/Guidance/InDevelopment/GID-CGWAVER123/Documents
|
4 |
Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581‐590.
DOI
ScienceOn
|
5 |
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
|
6 |
Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011;365:2255-2267.
DOI
ScienceOn
|
7 |
National Institute for Health and Care Excellence. 2014 NICE LIPID modification draft for consultation. England: National Institute for Health and Care Excellence, 2014. Available from: http://www.nice.org.uk/Guidance/InDevelopment/GID-CGWAVER123/Documents
|